Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 361 - 380 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18 19  20  21  22  23  24  25 »
Reset 

Statement from Jeff Shuren, M.D., J.D., director of the FDA's Center for Devices and Radiological Health, on agency's efforts to increase transparency in medical device reporting

SILVER SPRING, Md., June 21, 2019 /PRNewswire/ -- In the spirit of promoting public transparency, the U.S. Food and Drug Administration's Center for Devices and Radiological Health is taking a number of important steps to update its Medical Device Reporting (MDR) Program, one of the tools the... Read more ››

By: PR Newswire Association LLC. - 21 Jun 2019
Related companies:  U.S. Food and Drug Administration

Omron Healthcare Expands Alexa Skill for Its Connected Blood Pressure Monitors

LAKE FOREST, Ill., June 21, 2019 /PRNewswire/ -- In pursuit of its Going for Zero(TM) mission, Omron Healthcare, Inc., the global leader in personal heart health and wellness technology, today announced expanded capabilities for its connected blood pressure monitor users through the... Read more ››

By: PR Newswire Association LLC. - 21 Jun 2019

BioMarin Earns Milestone Payments from Pfizer for TALZENNA® (talazoparib) for Metastatic Breast Cancer Patients with an Inherited BRCA Mutation

SAN RAFAEL, Calif., June 21, 2019 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that the Company earned a $15 million milestone payment from Pfizer, Inc. This milestone payment was triggered by the European Commission (EC) approval of TALZENNA(®) (talazoparib) as... Read more ››

By: PR Newswire Association LLC. - 21 Jun 2019
Related companies:  BioMarin Pharmaceutical Inc.

Brainomix® Stroke Imaging Solution Improves Consistency of Image Interpretation for Doctors

New study shows Brainomix e-CTA® provides similar measures to experts and improves inter-rater reliability

Read more ››
By: PR Newswire Association LLC. - 21 Jun 2019

Chan Zuckerberg Initiative Awards $68 Million to Support the Growth of the Human Cell Atlas

REDWOOD CITY, Calif., June 21, 2019 /PRNewswire/ -- Today, the Chan Zuckerberg Initiative (CZI) announced $68 million in funding to support the Human Cell Atlas and its selection of Read more ››

By: PR Newswire Association LLC. - 21 Jun 2019

New Study Shows Cellulite Restored And Underlying Fibrotic Tissue Remodeled: Providing Hope For A Host Of Medical Issues

HOUSTON, June 21, 2019 /PRNewswire/ -- A new peer-reviewed study envisioned by Ashley... Read more ››

By: PR Newswire Association LLC. - 21 Jun 2019

Watercrest Senior Living Group Strengthens Memory Care Programming Promoting Sheena Jeffries to Engagement Specialist

VERO BEACH, Fla., June 21, 2019 /PRNewswire/ -- Watercrest Senior Living Group proudly announces the promotion... Read more ››

By: PR Newswire Association LLC. - 21 Jun 2019

Fujifilm to Showcase Array of Robust Technologies for Echocardiography at ASE 2019

LEXINGTON, Mass. and BOTHELL, Wash., June 21, 2019 /PRNewswire/ -- (Booth #500) -- Fujifilm will present its cardiovascular medical imaging portfolio including Read more ››

By: PR Newswire Association LLC. - 21 Jun 2019
Related companies:  FUJIFILM SonoSite, Inc

New research provides insight into immunity of lupus patients

MANHASSET, N.Y., June 21, 2019 /PRNewswire/ -- The Feinstein Institutes for Medical Research Professor... Read more ››

By: PR Newswire Association LLC. - 21 Jun 2019

The World Market for Neurovascular Guidewires, 2019: Analyzed by Type, Material Type, Application, End-user and Geography

DUBLIN, June 21, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 21 Jun 2019

FDA expands approval of treatment for cystic fibrosis to include patients ages 6 and older

SILVER SPRING, Md., June 21, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today expanded the indication for Symdeko (a combination of tezacaftor/ivacaftor) tablets for treatment of pediatric patients ages 6 years and older with cystic fibrosis who have certain genetic mutations.... Read more ››

By: PR Newswire Association LLC. - 21 Jun 2019
Related companies:  U.S. Food and Drug Administration

Bowes Dermatology by Riverchase is One of First Locations to Offer New miraDry

MIAMI, June 21, 2019 /PRNewswire/ -- Bowes Dermatology by Riverchase is pleased to announce the launch of breakthrough technology, miraDry. Bowes Dermatology by Riverchase is one of the first locations in the area to provide miraDry, which is clinically proven to eliminate sweat and odor glands.... Read more ››

By: PR Newswire Association LLC. - 21 Jun 2019
Related companies:  Sientra, Inc.

CannTrust Holdings Announces Voting Results from 2019 Annual and Special Meeting of Shareholders

VAUGHAN, ON, June 21, 2019 /PRNewswire/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX:TRST, NYSE:CTST) announces the voting results on the matters submitted to shareholders at the Company's Annual and Special Meeting of shareholders held on June 20, 2019. A total of 20,951,261... Read more ››

By: PR Newswire Association LLC. - 21 Jun 2019

Aurora Cannabis Prepared for Expansion of Canada's Cannabis Market

Efficient distribution, new partnerships and a broad range of high-margin products
to be launched in major consumer markets

Read more ››
By: PR Newswire Association LLC. - 21 Jun 2019

Zealand Pharma introduces new website to support people living with short bowel syndrome

Read more ››
By: Nasdaq / GlobenewsWire - 21 Jun 2019
Related companies:  Zealand Pharma A/S

AgraFlora Organics Secures 51,500 Sq. Ft Edibles Manufacturing Facility; Anticipates Q1 2020 Receipt of Health Canada Sales and Processing Licenses

Read more ››
By: Nasdaq / GlobenewsWire - 21 Jun 2019

German Federal Joint Committee (G-BA) Issues Exclusive Nationwide Reimbursement Decision for Oncotype DX Breast Recurrence Score® Test

Reimbursement Decision Follows IQWiG's Recommendation Based on TAILORx Study Results

Read more ››
By: PR Newswire Association LLC. - 21 Jun 2019

Achieve Life Sciences Announces Phase 2b ORCA-1 Trial Data Accepted for Oral Presentation at Society for Research on Nicotine & Tobacco Europe (SRNT-E) 19th Annual Conference

SEATTLE, Wash. and VANCOUVER, British Columbia, June 21, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company focused on nicotine addiction, today announced that an abstract featuring data from the Phase 2b ORCA-1 trial has been accepted for... Read more ››

By: PR Newswire Association LLC. - 21 Jun 2019
Related companies:  Achieve Life Sciences,Inc.

Sales of Hormone Replacement Therapy Products Set to Augment With Enhanced Government Support, Reports Fact.MR Study

ROCKVILLE, Maryland, June 21, 2019 /PRNewswire/ -- Based on the recently published Fact.MR report titled "Hormone Replacement Therapy Market Forecast, Trend Analysis & Competition Tracking... Read more ››

By: PR Newswire Association LLC. - 21 Jun 2019

Bone Therapeutics SA: Information on the total number of voting rights and shares

Read more ››
By: Nasdaq / GlobenewsWire - 21 Jun 2019
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18 19  20  21  22  23  24  25 »
to the top ↑